JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Custom and stocked solutions for COVID-19 programs.

CleanCap^®mRNA for rapid vaccine development and top-tier oligos to power diagnostic kits

CleanCap^® sets a new standard for superior mRNA translation.

Find out how CleanCap^® technology reduces cost while increasing efficiency.

Learn More

A clear path to the clinic with scalable manufacturing of mRNA, oligos, and custom reagents

TriLink BioTechnologies is expanding to a new global headquarters and state-of-the-art manufacturing campus. Our expertise is now combined with enhanced GMP capabilities to take your innovation from research to the clinic.

Learn More

About TriLink BioTechnologies

TriLink offers mRNA, oligo, and custom chemistry solutions as comprehensive CDMO services and through an expansive catalog menu. We empower research, diagnostic, vaccine, and therapeutic programs with critical reagents, expert scientific consultation, and flexible manufacturing support. Our manufacturing scales with your needs — from discovery to GMP grades. For over 20 years we have brought innovative technologies to the forefront of groundbreaking discoveries, such as CleanCap^®, a proprietary co-transcriptional mRNA capping technology that improves mRNA manufacturing compared with traditional capping methods by streamlining production and increasing yield.